X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa.Lapatto, R., Krengel, U., Schreuder, H.A., Arkema, A., de Boer, B., Kalk, K.H., Hol, W.G., Grootenhuis, P.D., Mulders, J.W., Dijkema, R., Theunissen, H.J., Dijkstra, B.W.
(1997) EMBO J. 16: 5151-5161
- PubMed: 9311976
- DOI: 10.1093/emboj/16.17.5151
- PubMed Abstract:
- Crystallization and Preliminary Crystallographic Analysis of Antistasin, a Leech-Derived Inhibitor of Blood Coagulation Factor Xa
Schreuder, H.,Arkema, A.,De Boer, B.,Kalk, K.,Dijkema, R.,Mulders, J.,Theunissen, H.,Hol, W.
(1993) J.Mol.Biol. 231: 1137
- Refined X-Ray Structure of Antistasin at 1.9 A Resolution
Krengel, U.,Lapatto, R.,Dijkstra, B.W.
(1996) Hasylab Jahresbericht --: 331
The three-dimensional structure of antistasin, a potent inhibitor of blood coagulation factor Xa, from the Mexican leech Haementeria officinalis was determined at 1.9 A resolution by X-ray crystallography. The structure reveals a novel protein fold c ...
The three-dimensional structure of antistasin, a potent inhibitor of blood coagulation factor Xa, from the Mexican leech Haementeria officinalis was determined at 1.9 A resolution by X-ray crystallography. The structure reveals a novel protein fold composed of two homologous domains, each resembling the structure of hirustasin, a related 55-residue protease inhibitor. However, hirustasin has a different overall shape than the individual antistasin domains, it contains four rather than two beta-strands, and does not inhibit factor Xa. The two antistasin domains can be subdivided into two similarly sized subdomains with different relative orientations. Consequently, the domain shapes are different, the N-terminal domain being wedge-shaped and the C-terminal domain flat. Docking studies suggest that differences in domain shape enable the N-terminal, but not C-terminal, domain of antistasin to bind and inhibit factor Xa, even though both have a very similar reactive site. Furthermore, a putative exosite binding region could be defined in the N-terminal domain of antistasin, comprising residues 15-17, which is likely to interact with a cluster of positively charged residues on the factor Xa surface (Arg222/Lys223/Lys224). This exosite binding region explains the specificity and inhibitory potency of antistasin towards factor Xa. In the C-terminal domain of antistasin, these exosite interactions are prevented due to the different overall shape of this domain.
Laboratory of Biophysical Chemistry and BIOSON Research Institute, Department of Chemistry, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands.